Skip to main content
. 2016 Apr 29;8:18. doi: 10.1186/s11689-016-9151-z

Table 1.

Brain tissue information for ASD patients and controls

Pair no. Case no.a BA Diagnosis Age (years)b Sex PMI (h)c Cause of death Intellectual disability Epilepsy Other features Drug therapies at time of deathd
1 AN11989 (B6677) 41/42 Autism 20 M 16 Cardiac arrest Yes Yes Heart medication, Zoloft, clomipramine
2 AN08792 (B5173) 41/42 Autism 30 M 20 Gastrointestinal hemorrhage Yes Yes Large ear lobes Dilantin, Depakote, Tranxene bid, cisapride, clorazepate, folic acid, oxcarbazepine
3 AN00764 (B5144) 22 Autism 20 M 23.7 Trauma Yes No None
4 AN17138 (B6294) 41/42 Autism 16 M Unknown Seizure Unknown Yes Inherited 15q duplication Topamax, Depakote, Allegra, Claritin, NuThera multivitamin
5 AN09730 (B6337) 22 Autism 22 M 25 Seizure Yes Yes Intestinal lymphadenopathy, hypertrophic spleen, recurrent otitis Lamictal, Zonegran, Neurontin, Abilify, flax seed oil, omega-3, multivitamin
6 AN01570 (B6184) 41/42 Autism 18 F 6.75 Seizure Unknown Yes Focal slowing in the left parieto-occipital area None
1 AN10833 (B5718) 41/42 Control 22 M 21.5 Unknown No No None
2 B4211 41/42 Control 30 M 23 Cardiac arrhythmia No No None
3 AN04432 (B3829) 22 Control 22 M 12 Central hepatic laceration No No None
4 AN17425 (B6207) 22 Control 16 M 26 Ischemic heart attack No No None
5 AN14368 (B6221) 41/42 Control 22 M 24 Unknown No No None
6 UMB1541 22 Control 20 F 19 Head injuries No No None

BA Brodmann area, PMI post-mortem interval

aAutism Tissue Program identifier

bMean age (±SD) for the autism group = 21.0±2.9, for controls = 22.0±1.8; t = −0.368, df = 10, p = 0.721

cMean PMI (±SD) for the autism group = 18.2+3.2, for controls = 20.9±2.0, t = −0.707, df = 9, p = 0.497

dPharmacological therapy from the last available report, dating back to less than a year prior to death